Digital Pathology
Digital Pathology: is an image-based information environment which is enabled by computer technology that allows for management of information generated from a digital slide. Digital pathology is enabled in part by virtual microscopy. Virtual microscopy is the practice of converting glass slides into digital slides that can be viewed, managed, shared and analyzed on a computer monitor. The field of digital pathology has exploded and is currently regarded as one of the most promising avenues of diagnostic medicine in order to achieve even better, faster and cheaper diagnosis, prognosis and prediction of cancer and other important diseases.
-
APR 16, 2020 9:00 AM PDTAdd to Calendar Select one of the following:
iCal
Google Calendar
Outlook Calendar
Yahoo Calendar
C.E. CREDITS
APR 16, 2020 9:00 AM PDTAdd to Calendar Select one of the following:
iCal
Google Calendar
Outlook Calendar
Yahoo Calendar
DATE: April 16, 2020 TIME: 9:00am PT, 12:00pm ET There is an increasing need to evaluate and understand unique phenotypes and mechanisms of action within the tumor microenvironment. Existing...Speaker: Karan SharmaSponsored By: UltivueMAR 03, 2020 9:00 AM PSTC.E. CREDITS
MAR 03, 2020 9:00 AM PSTDATE: March 3, 2020 TIME: 9:00am PT, 12:00pm ET Despite the advances of new drugs and the lowering of carbapenem breakpoints to enhance detection of CRE, there should be no complacency about...Speaker: Kenneth Thomson, PhDSponsored By: BDDEC 05, 2019 9:00 AM PSTC.E. CREDITS
DEC 05, 2019 9:00 AM PSTDATE: December 5, 2019TIME: 9:00am PST, 12:00pm EST Characterization of the spatial distribution and abundance of proteins and mRNAs with morphological context within tissues e...Speaker: Mathias Holpert, PhD , Traci DeGeer, BS, HT (ASCP) HTL, QIHCSponsored By: Leica Biosystems,NanoString TechnologiesSEP 26, 2019 9:00 AM PDTC.E. CREDITS
SEP 26, 2019 9:00 AM PDTEarly detection is critical for improved survival in melanoma. Melanocytic nevi are extremely common benign tumors that mimic melanoma and are therefore commonly biopsied. Currently, the dete...Speaker: Margaret Hoang, PhD , Maija Kiuru, PhDPresented at:Cell Biology 2019SEP 05, 2019 4:00 PM CESTC.E. CREDITS
SEP 05, 2019 4:00 PM CESTDATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...Speaker: Tim Schommartz, PhDSponsored By: EppendorfMAY 30, 2019 1:30 PM PDTC.E. CREDITS
MAY 30, 2019 1:30 PM PDTTissues in the body are wonderfully organized, with specific arrangements of cells, extracellular matrix, secreted molecules, and fluid flow that synergize that create emergent functions. How...Speaker: Rebecca Pompano, PhDPresented at:Laboratory Testing & Automation 2019MAY 30, 2019 12:00 PM PDTC.E. CREDITS
MAY 30, 2019 12:00 PM PDTThe attractiveness of 3D printing technology in the microfluidic field is growing, specifically stereolithographic (SLA) type 3D printers, owing to their low cost, versatility, fast and easy...Speaker: Mei He, PhDPresented at:Laboratory Testing & Automation 2019MAY 30, 2019 12:00 PM PDTC.E. CREDITS
MAY 30, 2019 12:00 PM PDTWith growing standards of patient care, clinical testing laboratory across the world are forced to change the way they manage their laboratory operations. More focus is now given to automatio...Speaker: Shonali Paul, MBAPresented at:Laboratory Testing & Automation 2019MAY 30, 2019 10:30 AM PDTC.E. CREDITS
MAY 30, 2019 10:30 AM PDTComputer vision (CV) has seen rapid growth in many industries, including the life sciences with high-content cell imaging and phenotypic assays. However, many biomolecular and cellular assay...Speaker: Amar Basu, PhDPresented at:Laboratory Testing & Automation 2019MAY 30, 2019 9:00 AM PDTC.E. CREDITS
MAY 30, 2019 9:00 AM PDTIn this seminar, Dr Elvira will talk about the use of droplet microfluidic technologies for drug discovery. Initially, she will discuss the fundamental concepts of droplet microfluidic techno...Speaker: Katherine Elvira, MSci, PhD, ARCSPresented at:Laboratory Testing & Automation 2019MAY 30, 2019 6:00 AM PDTC.E. CREDITS
MAY 30, 2019 6:00 AM PDTOncologists have many options when tasked with treating a patient’s cancer. Unfortunately, many cancer drugs and therapies come with potentially debilitating side effects. As such, it i...Speaker: Megan Dueck, PhDPresented at:Laboratory Testing & Automation 2019APR 25, 2019 10:30 AM PDTC.E. CREDITS
APR 25, 2019 10:30 AM PDTPoint-of-care testing (POCT) is diagnostic testing at the time and place of patient care in a physician’s office, an ambulance, a mobile clinic, at home or in hospital. Rapid POC testi...Speaker: Krishnan Allampallam, PhD , Paul Lambotte, PhDPresented at:Infectious Disease 2019Sponsored By: ChembioAPR 18, 2019 9:00 AM PDTC.E. CREDITS
Speaker: Aydogan Ozcan, PhD , Hongda Wang, MS, BS , Yair Rivenson, PhD , Laurent Bentolila, PhDSponsored By: Leica MicrosystemsAPR 10, 2019 1:30 PM PDTC.E. CREDITS
APR 10, 2019 1:30 PM PDTMyeloid leukemias encompass a group of different diseases that include myeloproliferative neoplasms (MPN), myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML). These diseases are d...Speaker: Véronique Laloux, PhD , Beate Litzenburger, PhDPresented at:Molecular Diagnostics 2019Sponsored By: QIAGENAPR 10, 2019 12:00 PM PDTC.E. CREDITS
APR 10, 2019 12:00 PM PDTPersonalized medicine driven by genomic-based treatments continues to increase in importance. Representatives from two distinct healthcare entities – a regional reference lab and commun...Speaker: Tony Magliocco, MD , Keith Gligorich, PhDPresented at:Molecular Diagnostics 2019Sponsored By: IlluminaAPR 10, 2019 12:00 PM PDTC.E. CREDITS
APR 10, 2019 12:00 PM PDTThe prevailing philosophy in biological testing has been to focus on simple tests with easy to interpret information such as ELISA or lateral flow assays. At the same time, there has been a d...Speaker: Brett Goldsmith, PhDPresented at:Molecular Diagnostics 2019MAR 05, 2019 10:00 AM PSTC.E. CREDITS
MAR 05, 2019 10:00 AM PSTDATE: March 5, 2019TIME: 10:00am PSTSingle cell analysis, starting with the earliest low parameter fluorescent experiments, helped define the major cell subsets of human ce...Speaker: Sean Bendall, PhDSponsored By: IONpathFEB 13, 2019 7:30 AM PSTC.E. CREDITS
FEB 13, 2019 7:30 AM PSTDigitalization has transformed virtually every industry, but it has been slow to gain traction within the preclinical phase of the drug development journey. Recent advances in digital vivariu...Speaker: Szczepan Baran, VMD, MSPresented at:Laboratory Animal Sciences 2019NOV 15, 2018 10:00 AM PSTC.E. CREDITS
NOV 15, 2018 10:00 AM PSTDATE: November 15, 2018TIME: 10:00am PT, 1:00pm ET Multiplex fluorescence immunohistochemistry offers a window into the biology of human disease, enabling the ana...Speaker: Traci DeGeer, BS, HT (ASCP) HTL, QIHC , Alexander KlimowiczSponsored By: Leica BiosystemsOCT 11, 2018 1:30 PM PDTC.E. CREDITS
OCT 11, 2018 1:30 PM PDTAs the most common female malignancy, breast cancer is the most likely reason that a woman will die of cancer around the world. Breast cancer mortality has dropped in the U.S. by 35% since 19...Speaker: Benjamin Anderson, MDPresented at:Cancer Research & Oncology 2018OCT 11, 2018 12:00 PM PDTC.E. CREDITS
OCT 11, 2018 12:00 PM PDTLung cancer is the leading cause of cancer-related mortality worldwide. Large-scale sequencing studies have revealed the complex genomic landscape of NSCLC and genomic differences between lun...Speaker: Nicholas McGranahan, PhDPresented at:Cancer Research & Oncology 2018OCT 11, 2018 10:30 AM PDTC.E. CREDITS
OCT 11, 2018 10:30 AM PDTTwo projects looking at novel approaches to targeting inflammatory breast cancer will be presented. Inflammatory breast cancer (IBC) is a unique, understudied, and most lethal subtype account...Speaker: Kevin Williams, PhDPresented at:Cancer Research & Oncology 2018OCT 11, 2018 9:00 AM PDTC.E. CREDITS
OCT 11, 2018 9:00 AM PDTThe oncogenic transcription factor c-MYC (MYC) is deregulated, and often overexpressed, in more than 50% of cancers. MYC deregulation is associated with poor prognosis and aggressive disease,...Speaker: Jason De Melo, PhDPresented at:Cancer Research & Oncology 2018OCT 11, 2018 7:30 AM PDTC.E. CREDITS
OCT 11, 2018 7:30 AM PDTIn the past two decades a small number of infrequently dividing cells have been proposed as the source of multi-drug resistance during cancer treatment. These cells identified by their expres...Speaker: Krastan Blagoev, PhDPresented at:Cancer Research & Oncology 2018
APR 16, 2020
9:00 AM PDT
Add to Calendar
Select one of the following:
iCal
Google Calendar
Outlook Calendar
Yahoo Calendar
iCal
Google Calendar
Outlook Calendar
Yahoo Calendar
C.E. CREDITS
APR 16, 2020
9:00 AM PDT
Add to Calendar
Select one of the following:
iCal
Google Calendar
Outlook Calendar
Yahoo Calendar
iCal
Google Calendar
Outlook Calendar
Yahoo Calendar
DATE: April 16, 2020 TIME: 9:00am PT, 12:00pm ET There is an increasing need to evaluate and understand unique phenotypes and mechanisms of action within the tumor microenvironment. Existing...
Speaker:
Karan Sharma
Sponsored By: Ultivue
MAR 03, 2020
9:00 AM PST
C.E. CREDITS
MAR 03, 2020
9:00 AM PST
DATE: March 3, 2020 TIME: 9:00am PT, 12:00pm ET Despite the advances of new drugs and the lowering of carbapenem breakpoints to enhance detection of CRE, there should be no complacency about...
Speaker:
Kenneth Thomson, PhD
Sponsored By: BD
DEC 05, 2019
9:00 AM PST
C.E. CREDITS
DEC 05, 2019
9:00 AM PST
DATE: December 5, 2019TIME: 9:00am PST, 12:00pm EST Characterization of the spatial distribution and abundance of proteins and mRNAs with morphological context within tissues e...
Speaker:
Mathias Holpert, PhD
,
Traci DeGeer, BS, HT (ASCP) HTL, QIHC
Sponsored By: Leica Biosystems,
NanoString Technologies
SEP 26, 2019
9:00 AM PDT
C.E. CREDITS
SEP 26, 2019
9:00 AM PDT
Early detection is critical for improved survival in melanoma. Melanocytic nevi are extremely common benign tumors that mimic melanoma and are therefore commonly biopsied. Currently, the dete...
Speaker:
Margaret Hoang, PhD
,
Maija Kiuru, PhD
Presented at:Cell Biology 2019
SEP 05, 2019
4:00 PM CEST
C.E. CREDITS
SEP 05, 2019
4:00 PM CEST
DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
Speaker:
Tim Schommartz, PhD
Sponsored By: Eppendorf
MAY 30, 2019
1:30 PM PDT
C.E. CREDITS
MAY 30, 2019
1:30 PM PDT
Tissues in the body are wonderfully organized, with specific arrangements of cells, extracellular matrix, secreted molecules, and fluid flow that synergize that create emergent functions. How...
Speaker:
Rebecca Pompano, PhD
Presented at:Laboratory Testing & Automation 2019
MAY 30, 2019
12:00 PM PDT
C.E. CREDITS
MAY 30, 2019
12:00 PM PDT
The attractiveness of 3D printing technology in the microfluidic field is growing, specifically stereolithographic (SLA) type 3D printers, owing to their low cost, versatility, fast and easy...
Speaker:
Mei He, PhD
Presented at:Laboratory Testing & Automation 2019
MAY 30, 2019
12:00 PM PDT
C.E. CREDITS
MAY 30, 2019
12:00 PM PDT
With growing standards of patient care, clinical testing laboratory across the world are forced to change the way they manage their laboratory operations. More focus is now given to automatio...
Speaker:
Shonali Paul, MBA
Presented at:Laboratory Testing & Automation 2019
MAY 30, 2019
10:30 AM PDT
C.E. CREDITS
MAY 30, 2019
10:30 AM PDT
Computer vision (CV) has seen rapid growth in many industries, including the life sciences with high-content cell imaging and phenotypic assays. However, many biomolecular and cellular assay...
Speaker:
Amar Basu, PhD
Presented at:Laboratory Testing & Automation 2019
MAY 30, 2019
9:00 AM PDT
C.E. CREDITS
MAY 30, 2019
9:00 AM PDT
In this seminar, Dr Elvira will talk about the use of droplet microfluidic technologies for drug discovery. Initially, she will discuss the fundamental concepts of droplet microfluidic techno...
Speaker:
Katherine Elvira, MSci, PhD, ARCS
Presented at:Laboratory Testing & Automation 2019
MAY 30, 2019
6:00 AM PDT
C.E. CREDITS
MAY 30, 2019
6:00 AM PDT
Oncologists have many options when tasked with treating a patient’s cancer. Unfortunately, many cancer drugs and therapies come with potentially debilitating side effects. As such, it i...
Speaker:
Megan Dueck, PhD
Presented at:Laboratory Testing & Automation 2019
APR 25, 2019
10:30 AM PDT
C.E. CREDITS
APR 25, 2019
10:30 AM PDT
Point-of-care testing (POCT) is diagnostic testing at the time and place of patient care in a physician’s office, an ambulance, a mobile clinic, at home or in hospital. Rapid POC testi...
Speaker:
Krishnan Allampallam, PhD
,
Paul Lambotte, PhD
Presented at:Infectious Disease 2019
Sponsored By: Chembio
APR 18, 2019
9:00 AM PDT
C.E. CREDITS
Speaker:
Aydogan Ozcan, PhD
,
Hongda Wang, MS, BS
,
Yair Rivenson, PhD
,
Laurent Bentolila, PhD
Sponsored By: Leica Microsystems
APR 10, 2019
1:30 PM PDT
C.E. CREDITS
APR 10, 2019
1:30 PM PDT
Myeloid leukemias encompass a group of different diseases that include myeloproliferative neoplasms (MPN), myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML). These diseases are d...
Speaker:
Véronique Laloux, PhD
,
Beate Litzenburger, PhD
Presented at:Molecular Diagnostics 2019
Sponsored By: QIAGEN
APR 10, 2019
12:00 PM PDT
C.E. CREDITS
APR 10, 2019
12:00 PM PDT
Personalized medicine driven by genomic-based treatments continues to increase in importance. Representatives from two distinct healthcare entities – a regional reference lab and commun...
Speaker:
Tony Magliocco, MD
,
Keith Gligorich, PhD
Presented at:Molecular Diagnostics 2019
Sponsored By: Illumina
APR 10, 2019
12:00 PM PDT
C.E. CREDITS
APR 10, 2019
12:00 PM PDT
The prevailing philosophy in biological testing has been to focus on simple tests with easy to interpret information such as ELISA or lateral flow assays. At the same time, there has been a d...
Speaker:
Brett Goldsmith, PhD
Presented at:Molecular Diagnostics 2019
MAR 05, 2019
10:00 AM PST
C.E. CREDITS
MAR 05, 2019
10:00 AM PST
DATE: March 5, 2019TIME: 10:00am PSTSingle cell analysis, starting with the earliest low parameter fluorescent experiments, helped define the major cell subsets of human ce...
Speaker:
Sean Bendall, PhD
Sponsored By: IONpath
FEB 13, 2019
7:30 AM PST
C.E. CREDITS
FEB 13, 2019
7:30 AM PST
Digitalization has transformed virtually every industry, but it has been slow to gain traction within the preclinical phase of the drug development journey. Recent advances in digital vivariu...
Speaker:
Szczepan Baran, VMD, MS
Presented at:Laboratory Animal Sciences 2019
NOV 15, 2018
10:00 AM PST
C.E. CREDITS
NOV 15, 2018
10:00 AM PST
DATE: November 15, 2018TIME: 10:00am PT, 1:00pm ET Multiplex fluorescence immunohistochemistry offers a window into the biology of human disease, enabling the ana...
Speaker:
Traci DeGeer, BS, HT (ASCP) HTL, QIHC
,
Alexander Klimowicz
Sponsored By: Leica Biosystems
OCT 11, 2018
1:30 PM PDT
C.E. CREDITS
OCT 11, 2018
1:30 PM PDT
As the most common female malignancy, breast cancer is the most likely reason that a woman will die of cancer around the world. Breast cancer mortality has dropped in the U.S. by 35% since 19...
Speaker:
Benjamin Anderson, MD
Presented at:Cancer Research & Oncology 2018
OCT 11, 2018
12:00 PM PDT
C.E. CREDITS
OCT 11, 2018
12:00 PM PDT
Lung cancer is the leading cause of cancer-related mortality worldwide. Large-scale sequencing studies have revealed the complex genomic landscape of NSCLC and genomic differences between lun...
Speaker:
Nicholas McGranahan, PhD
Presented at:Cancer Research & Oncology 2018
OCT 11, 2018
10:30 AM PDT
C.E. CREDITS
OCT 11, 2018
10:30 AM PDT
Two projects looking at novel approaches to targeting inflammatory breast cancer will be presented. Inflammatory breast cancer (IBC) is a unique, understudied, and most lethal subtype account...
Speaker:
Kevin Williams, PhD
Presented at:Cancer Research & Oncology 2018
OCT 11, 2018
9:00 AM PDT
C.E. CREDITS
OCT 11, 2018
9:00 AM PDT
The oncogenic transcription factor c-MYC (MYC) is deregulated, and often overexpressed, in more than 50% of cancers. MYC deregulation is associated with poor prognosis and aggressive disease,...
Speaker:
Jason De Melo, PhD
Presented at:Cancer Research & Oncology 2018
OCT 11, 2018
7:30 AM PDT
C.E. CREDITS
OCT 11, 2018
7:30 AM PDT
In the past two decades a small number of infrequently dividing cells have been proposed as the source of multi-drug resistance during cancer treatment. These cells identified by their expres...
Speaker:
Krastan Blagoev, PhD
Presented at:Cancer Research & Oncology 2018
- Augmented Reality
- Histopathology
- Clinical Psychology
- Publishing
- Tolerance
- Primate
- Plant Pathology
- Virtual Reality
- Motivation
- Digitalization
- Behavioral Neuroscience
- Research
- Social Behavior
- Research and Development
- Exome Sequencing
- University
- Cytopathology
- Behavior
- Behavioral Research
- Animals
- Animal Behavior
- Animal Research
- Multiple System Atrophy (MSA)
- Psychoanalysis
- Psychosomatic Medicine
- Psychotherapy
- Whole Genome Sequencing
- Pathology
- Coding
- Computational Neuroscience
